SPA
Sherbrooke Park Advisers’s Cytek Biosciences CTKB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-22,314
| Closed | -$89.5K | – | 568 |
|
|
2025
Q1 | $89.5K | Sell |
22,314
-19,460
| -47% | -$78K | 0.04% | 525 |
|
|
2024
Q4 | $271K | Sell |
41,774
-62,612
| -60% | -$406K | 0.09% | 451 |
|
|
2024
Q3 | $578K | Buy |
104,386
+74,402
| +248% | +$412K | 0.13% | 250 |
|
|
2024
Q2 | $167K | Sell |
29,984
-55,850
| -65% | -$312K | 0.03% | 790 |
|
|
2024
Q1 | $576K | Buy |
+85,834
| New | +$576K | 0.11% | 318 |
|
|
2023
Q4 | – | Sell |
-15,656
| Closed | -$86.4K | – | 505 |
|
|
2023
Q3 | $86.4K | Buy |
+15,656
| New | +$86.4K | 0.03% | 465 |
|